Comparison of Topical Use of Platelet-rich Plasma Versus Hyaluronic Acid During Endoscopic Fat Graft Myringoplasty: a Randomized Clinical Study
NCT06505252 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2024-07-17
Summary
This study aimed to compare the effect of adding HA versus PRP to endoscopic FGM in cases of small or medium-sized central TM perforation in the form of:
1. Evaluation of the graft uptake rate.
2. Evaluation and comparing audiological outcomes.
3. Finding out intraoperative and postoperative morbidity.
Conditions
- Chronic Suppurative Otitis Media
Interventions
- PROCEDURE
-
enoscopic Myringoplasty
general anesthesia. A single surgeon will perform all surgeries. * A small incision in the rim of ear lobule on the same side of the operated ear, a small piece of adipose tissue will be removed according to the experience of the surgeon. * Using 0 angulation endoscope visualization, the edges of the perforation will be refreshed and deepithelialized with a sharp Rosen's needle * sponge gel (Gelfoam) will pushed through TM perforation into the middle ear to support the graft and to avoid its medialization * the previously removed fat graft will be inserted through the perforation adjusted so most of the fat piece lying medial to the perforation and small part laterally in patients group A: 0.5 mL of HA vial will be injected directly over the fat graft and the TM remnant. After 5 minutes small gelfoam pieces soaked in 0.5 mL of HA vial will applied over the fat in patients group B PRPG was inserted into the external auditory canal on the outer face of the TM remnant and fat
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 14 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-30
- Primary Completion
- 2026-07-09
- Completion
- 2026-10-10
More Related Trials
-
Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.
NCT05786378 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18
NCT02550314 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Autologous Plasma Rich in Platelets and Extracellular Vesicles in the Surgical Treatment of Chronic Middle Ear Infections
NCT04761562 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Endoscopic Tympanoplasty: Single Versus Double Flap Technique
NCT03922295 ·Status: COMPLETED ·Phase: NA
-
Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss
NCT02105441 ·Status: COMPLETED
-
Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss
NCT07235488 ·Status: RECRUITING ·Phase: NA
-
Tranexamic Acid Versus Epinephrine During Exploratory Tympanotomy
NCT04188184 ·Status: COMPLETED ·Phase: NA
-
Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1
NCT01925482 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison Tympanoplasty With Membrane Amniotic and Autologous Fascia
NCT03569969 ·Status: COMPLETED ·Phase: NA
-
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
NCT04960384 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
NCT01270282 ·Status: COMPLETED ·Phase: PHASE2
-
Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)
NCT04774250 ·Status: TERMINATED ·Phase: PHASE2
-
Hearing Preservation Using Dexamethasone and Hyaluronic Acid for Cochlear Implantation
NCT01588925 ·Status: COMPLETED ·Phase: PHASE2
-
Repair of Tympanic Membrane Perforation Using Tachosil Under Local Anesthesia
NCT04428463 ·Status: UNKNOWN ·Phase: NA
-
Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss
NCT04766853 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss
NCT06437054 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
The Effect of PAP on ISSHL Comorbided With OSA
NCT04192656 ·Status: RECRUITING ·Phase: PHASE4
-
Use of Biodesign® Otologic Graft in Tympanoplasty
NCT03904316 ·Status: WITHDRAWN ·Phase: PHASE4
-
FX-322 in Adults With Severe Sensorineural Hearing Loss
NCT04629664 ·Status: COMPLETED ·Phase: PHASE1
-
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2
NCT00694421 ·Status: COMPLETED
-
Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
NCT02259595 ·Status: COMPLETED ·Phase: PHASE1
-
TNF-α Treatment of Blast-Induced Tinnitus
NCT04066348 ·Status: RECRUITING ·Phase: PHASE2
-
Establishment of a Trans-round Window Inner Ear Continuous Drug Delivery System for the Treatment of Severe-to-profound Sudden Sensorineural Hearing Loss
NCT05455398 ·Status: UNKNOWN ·Phase: NA
-
In-office Repair of Chronic Tympanic Membrane Perforations
NCT06448039 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
NCT02307916 ·Status: COMPLETED ·Phase: PHASE2